Pituitary & hypothalamus

Risk of new endocrinological deficits after intraoperative MRI-guided additional resection in endoscopic non-functioning pituitary adenoma surgery

PituitaryPublished Retrospective cohort study

Authors' conclusion

IoMRI-guided additional resection during TSS for NFPAs can be performed safely without increasing the risk of new EDs.

Study context

Population
Patients with histologically confirmed NFPA undergoing endoscopic transsphenoidal surgery with 3-Tesla intraoperative magnetic resonance imaging (ioMRI), July 2013–July 2022; median age 60 years, 59% maleof 312 screened
Participants
155 patients
Exposure
ioMRI-guided additional resection vs no additional resection
Outcome
New endocrinological deficits (EDs) of at least one pituitary axis
Methodological detailsprospectively collected data, 3-Tesla ioMRI, endoscopic transsphenoidal surgery with "chopsticks" technique
  • Prospectively collected data
  • 3-Tesla ioMRI
  • Endoscopic transsphenoidal surgery with "chopsticks" technique

Main finding

As reported in the abstract

New EDs of at least one pituitary axis

New endocrinological deficits (EDs) at discharge

23%

n = 35

New EDs at first follow-up (6 weeks)

25%

n = 38

New EDs at final follow-up

18%

n = 28

Observational data: associations, not effects.

Further findings

Gross total resection (GTR) rate

ioMRI GTR rate
35%
GTR on 3-month postoperative MRI after ioMRI-guided additional resection
65% (n = 98)
Additional resection following ioMRI
46% (n = 71)

Any recovery of preoperative EDs · discharge, 6 weeks, final follow-up

Recovery at discharge
9.7%
Recovery at first follow-up
31%
Recovery at final follow-up
45%

Original publication

Risk of new endocrinological deficits after intraoperative MRI-guided additional resection in endoscopic non-functioning pituitary adenoma surgery. Pituitary. Published 11 July 2026. doi:10.1007/s11102-026-01727-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.